Evelyn Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.52M Sell
9,651
-150
-2% -$38.5K 0.04% 148
2026
Q2
$2.47M Buy
+9,801
New +$2.11M 0.01% 132

Other funds holding ABBV

Evelyn Partners's ABBV Position: Q3 2026 in Review

Evelyn Partners reduced its AbbVie (ABBV) stake by 1.5% in Q3 2026, selling an estimated $38.5K and leaving 9,651 shares worth $2.52M. The position accounts for 0.04% of the portfolio, ranked #148.

Evelyn Partners first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Evelyn Partners held 9,651 shares of AbbVie worth $2.52M as of Q3 2026.
  • Evelyn Partners sold 150 AbbVie shares in Q3 2026, an estimated $38.5K.
  • AbbVie made up 0.04% of Evelyn Partners's portfolio in Q3 2026, its #148 holding.
  • Evelyn Partners first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.